Abordaje de factores contribuyentes: Evaluar y tratar condiciones coexistentes que dificultan la prdida de peso: resistencia a la insulina, sndrome de ovario poliqustico, apnea del sueo, deficiencia de vitamina D (comn en Hashimoto) y trastornos del estado de nimo
Terushkin quickly identified the link to Mounjaro's effects and advised a multi-pronged strategy
When starting tirzepatide therapy, the opening dose is strategically low to allow your body to adapt, then gradually increases over weeks based on your response and tolerance
Retatrutide is a novel once-weekly triple agonist for the GLP-1R, GIPR, and GCGR receptors, showing a stronger action on the human GIP receptor, and exerting weaker effects on the GLP-1 and glucagon receptors
It means the recommendations in this guide are built on mechanistic reasoning and clinical experience rather than dedicated trial data
Rinninella E, Cintoni M, Raoul P, et al